Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Indian Seed Sector Analysis Market

ID: MRFR/Agri/23293-HCR
128 Pages
Snehal Singh
Last Updated: April 08, 2026

Indian Seed Sector Analysis Market Size, Share, Industry Trend & Analysis Research Report By Crop Type (Cereals & Millets, Oilseeds, Pulses, Vegetables, Fruits, Flowers), By Seed Type (Hybrid Seeds, Genetically Modified (GM) Seeds, Conventional Seeds), By Application (Field Crops, Horticulture Crops, Forage Crops), By Distribution Channel (Direct Sales, Distributors, Retailers, Online Platforms) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Pharmaceutical, BY Application (USD Billion) | |
      1. 4.1.1 Field Crops | |
      2. 4.1.2 Horticultural Crops | |
      3. 4.1.3 Forage Crops | |
      4. 4.1.4 Vegetable Crops |
    2. 4.2 Pharmaceutical, BY Seed Type (USD Billion) | |
      1. 4.2.1 Hybrid Seeds | |
      2. 4.2.2 Open Pollinated Seeds | |
      3. 4.2.3 Genetically Modified Seeds | |
      4. 4.2.4 Organic Seeds |
    3. 4.3 Pharmaceutical, BY Distribution Channel (USD Billion) | |
      1. 4.3.1 Direct Sales | |
      2. 4.3.2 Retail Sales | |
      3. 4.3.3 Online Sales | |
      4. 4.3.4 Wholesale |
    4. 4.4 Pharmaceutical, BY End Use (USD Billion) | |
      1. 4.4.1 Agriculture | |
      2. 4.4.2 Research | |
      3. 4.4.3 Commercial Farming | |
      4. 4.4.4 Home Gardening |
    5. 4.5 Pharmaceutical, BY Seed Treatment (USD Billion) | |
      1. 4.5.1 Chemical Treatment | |
      2. 4.5.2 Biological Treatment | |
      3. 4.5.3 Physical Treatment | |
      4. 4.5.4 Seed Coating 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Mahyco (IN) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Bayer CropScience (DE) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Syngenta (CH) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 DuPont (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Nuziveedu Seeds (IN) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Kaveri Seed Company (IN) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Rallis India (IN) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Advanta Seeds (IN) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Pioneer Hi-Bred (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 INDIA MARKET ANALYSIS BY APPLICATION |
    6. 6.3 INDIA MARKET ANALYSIS BY SEED TYPE |
    7. 6.4 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL |
    8. 6.5 INDIA MARKET ANALYSIS BY END USE |
    9. 6.6 INDIA MARKET ANALYSIS BY SEED TREATMENT |
    10. 6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL |
    11. 6.8 RESEARCH PROCESS OF MRFR |
    12. 6.9 DRO ANALYSIS OF PHARMACEUTICAL |
    13. 6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL |
    14. 6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL |
    15. 6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL |
    16. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE) |
    17. 6.14 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    18. 6.15 PHARMACEUTICAL, BY SEED TYPE, 2024 (% SHARE) |
    19. 6.16 PHARMACEUTICAL, BY SEED TYPE, 2024 TO 2035 (USD Billion) |
    20. 6.17 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE) |
    21. 6.18 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion) |
    22. 6.19 PHARMACEUTICAL, BY END USE, 2024 (% SHARE) |
    23. 6.20 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Billion) |
    24. 6.21 PHARMACEUTICAL, BY SEED TREATMENT, 2024 (% SHARE) |
    25. 6.22 PHARMACEUTICAL, BY SEED TREATMENT, 2024 TO 2035 (USD Billion) |
    26. 6.23 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    27. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    28. 7.2 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion) | |
      2. 7.2.2 BY SEED TYPE, 2026-2035 (USD Billion) | |
      3. 7.2.3 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion) | |
      4. 7.2.4 BY END USE, 2026-2035 (USD Billion) | |
      5. 7.2.5 BY SEED TREATMENT, 2026-2035 (USD Billion) |
    29. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    30. 7.4 ACQUISITION/PARTNERSHIP | |

India Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Billion, 2026-2035)

  • Field Crops
  • Horticultural Crops
  • Forage Crops
  • Vegetable Crops

Pharmaceutical By Seed Type (USD Billion, 2026-2035)

  • Hybrid Seeds
  • Open Pollinated Seeds
  • Genetically Modified Seeds
  • Organic Seeds

Pharmaceutical By Distribution Channel (USD Billion, 2026-2035)

  • Direct Sales
  • Retail Sales
  • Online Sales
  • Wholesale

Pharmaceutical By End Use (USD Billion, 2026-2035)

  • Agriculture
  • Research
  • Commercial Farming
  • Home Gardening

Pharmaceutical By Seed Treatment (USD Billion, 2026-2035)

  • Chemical Treatment
  • Biological Treatment
  • Physical Treatment
  • Seed Coating

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions